Cargando…

A national case-crossover analysis of the short-term effect of PM(2.5) on hospitalizations and mortality in subjects with diabetes and neurological disorders

BACKGROUND: Diabetes and neurological disorders are a growing burden among the elderly, and may also make them more susceptible to particulate air matter with aerodynamic diameter less than 2.5 μg (PM(2.5)). The same biological responses thought to effect cardiovascular disease through air pollution...

Descripción completa

Detalles Bibliográficos
Autores principales: Zanobetti, Antonella, Dominici, Francesca, Wang, Yun, Schwartz, Joel D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064518/
https://www.ncbi.nlm.nih.gov/pubmed/24886318
http://dx.doi.org/10.1186/1476-069X-13-38
Descripción
Sumario:BACKGROUND: Diabetes and neurological disorders are a growing burden among the elderly, and may also make them more susceptible to particulate air matter with aerodynamic diameter less than 2.5 μg (PM(2.5)). The same biological responses thought to effect cardiovascular disease through air pollution-mediated systemic oxidative stress, inflammation and cerebrovascular dysfunction could also be relevant for diabetes and neurodegenerative diseases. METHODS: We conducted multi-site case-crossover analyses of all-cause deaths and of hospitalizations for diabetes or neurological disorders among Medicare enrollees (>65 years) during the period 1999 to 2010 in 121 US communities. We examined whether 1) short-term exposure to PM(2.5) increases the risk of hospitalization for diabetes or neurological disorders, and 2) the association between short-term exposure to PM(2.5) and all-cause mortality is modified by having a previous hospitalization of diabetes or neurological disorders. RESULTS: We found that short term exposure to PM(2.5) is significantly associated with an increase in hospitalization risks for diabetes (1.14% increase, 95% CI: 0.56, 1.73 for a 10 μg/m(3) increase in the 2 days average), and for Parkinson’s disease (3.23%, 1.08, 5.43); we also found an increase in all-cause mortality risks (0.64%, 95% CI: 0.42, 0.85), but we didn’t find that hospitalization for diabetes and neurodegenerative diseases modifies the association between short term exposure to PM(2.5) and all-cause mortality. CONCLUSION: We found that short-term exposure to fine particles increased the risk of hospitalizations for Parkinson’s disease and diabetes, and of all-cause mortality. While the association between short term exposure to PM(2.5) and mortality was higher among Medicare enrollees that had a previous admission for diabetes and neurological disorders than among Medicare enrollees that did not had a prior admission for these diseases, the effect modification was not statistically significant. We believe that these results provide useful insights regarding the mechanisms by which particles may affect the brain. A better understanding of the mechanisms will enable the development of new strategies to protect individuals at risk and to reduce detrimental effects of air pollution on the nervous system.